[Cryptococcosis of the central nervous system with cellular immune reaction disorders].
D000935:Antifungal Agents / Q000627:therapeutic use; D001555:Benzene Derivatives / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000150:complications* / Q000188:drug therapy; D002648:Child; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications*
D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles; D005437:Flucytosine
Cryptococcose des Zentralnervensystems mit Störung der zellulären Immunreaktionen